|
Detailed Information
-
May 5, 2024
1:00pm - 5:00pm
Type: Short Course
Capacity: 111
The value of medical innovation varies by stakeholder
perspective. Registration authorities focus on clinical value for patients.
Payers focus on economic value, including equity, and reward value to
incentivize optimal innovation. Sustainable value-based pricing must also meet
investor needs. We explore these perspectives, focusing on orphan diseases and,
specifically, cell and gene therapies. ...
|
|
|
|